Eculizumab in Asian patients with anti-aquaporin-IgG-positive neuromyelitis optica spectrum disorder: A subgroup analysis from the randomized phase 3 PREVENT trial and its open-label extension

on behalf of the PREVENT Study Group

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Eculizumab in Asian patients with anti-aquaporin-IgG-positive neuromyelitis optica spectrum disorder: A subgroup analysis from the randomized phase 3 PREVENT trial and its open-label extension'. Together they form a unique fingerprint.

Medicine & Life Sciences